These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 20031289
1. Relationship of synovial tumor necrosis factor alpha and interleukin 6 to temporomandibular disorder. Lee JK, Cho YS, Song SI. J Oral Maxillofac Surg; 2010 May; 68(5):1064-8. PubMed ID: 20031289 [Abstract] [Full Text] [Related]
2. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Br J Oral Maxillofac Surg; 2002 Oct; 40(5):418-23. PubMed ID: 12379189 [Abstract] [Full Text] [Related]
3. Effect of temporomandibular joint arthrocentesis on synovial fluid mediator level of tumor necrosis factor-alpha: implications for treatment outcome. Emshoff R, Puffer P, Strobl H, Gassner R. Int J Oral Maxillofac Surg; 2000 Jun; 29(3):176-82. PubMed ID: 10970078 [Abstract] [Full Text] [Related]
4. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832 [Abstract] [Full Text] [Related]
5. Temporomandibular joint pressure pain threshold is systemically modulated in rheumatoid arthritis. Alstergren P, Fredriksson L, Kopp S. J Orofac Pain; 2008 Mar; 22(3):231-8. PubMed ID: 18780536 [Abstract] [Full Text] [Related]
6. Analysis of inflammatory mediators in temporomandibular joint synovial fluid lavage samples of symptomatic patients and asymptomatic controls. Chang H, Israel H. J Oral Maxillofac Surg; 2005 Jun; 63(6):761-5. PubMed ID: 15944971 [Abstract] [Full Text] [Related]
7. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis. Kopp S, Alstergren P, Ernestam S, Nordahl S, Morin P, Bratt J. Cells Tissues Organs; 2005 Jun; 180(1):22-30. PubMed ID: 16088130 [Abstract] [Full Text] [Related]
8. Neuroendocrine, immune, and local responses related to temporomandibular disorders. Kopp S. J Orofac Pain; 2001 Jun; 15(1):9-28. PubMed ID: 11889652 [Abstract] [Full Text] [Related]
9. Cytokine and clinical predictors for treatment outcome of visually guided temporomandibular joint irrigation in patients with chronic closed lock. Hamada Y, Kondoh T, Holmlund AB, Sakota K, Nomura Y, Seto K. J Oral Maxillofac Surg; 2008 Jan; 66(1):29-34. PubMed ID: 18083412 [Abstract] [Full Text] [Related]
11. Comparison of cytokine level in synovial fluid between successful and unsuccessful cases in arthrocentesis of the temporomandibular joint. Nishimura M, Segami N, Kaneyama K, Sato J, Fujimura K. J Oral Maxillofac Surg; 2004 Mar; 62(3):284-7; discussion 287-8. PubMed ID: 15015157 [Abstract] [Full Text] [Related]
12. Tumor necrosis factor-alpha in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment. Fredriksson L, Alstergren P, Kopp S. Mediators Inflamm; 2006 Mar; 2006(6):59425. PubMed ID: 17392588 [Abstract] [Full Text] [Related]
13. Temporomandibular joint pain and synovial fluid analysis: a review of the literature. Bouloux GF. J Oral Maxillofac Surg; 2009 Nov; 67(11):2497-504. PubMed ID: 19837323 [Abstract] [Full Text] [Related]
14. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. Madson KL, Moore TL, Lawrence JM, Osborn TG. J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643 [Abstract] [Full Text] [Related]
15. Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. Hay CW, Chu Q, Budsberg SC, Clayton MK, Johnson KA. Am J Vet Res; 1997 Sep; 58(9):1027-32. PubMed ID: 9285010 [Abstract] [Full Text] [Related]
16. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. Hawkins DL, Cargile JL, MacKay RJ, Broome TA, Skelley LA. Am J Vet Res; 1995 Oct; 56(10):1292-9. PubMed ID: 8928945 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. Shafer DM, Assael L, White LB, Rossomando EF. J Oral Maxillofac Surg; 1994 Aug; 52(8):786-91; discussion 791-2. PubMed ID: 8040729 [Abstract] [Full Text] [Related]
18. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. Saxena N, Aggarwal A, Misra R. J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076 [Abstract] [Full Text] [Related]
19. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study. Kim YK, Kim SG, Kim BS, Lee JY, Yun PY, Bae JH, Oh JS, Ahn JM, Kim JS, Lee SY. J Craniomaxillofac Surg; 2012 Dec; 40(8):e337-41. PubMed ID: 22425498 [Abstract] [Full Text] [Related]
20. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]